Mani Foroohar
Stock Analyst at Leerink Partners
(0)
# 3380
Out of 5,240 analysts
210
Total ratings
39.22%
Success rate
0.89%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
4D Molecular Therape... | Maintains: Outperform | 31 27 | 5 | 440% | 9 | Jan 13, 2025 | |
Rocket Pharmaceutica... | Maintains: Outperform | 46 44 | 10.75 | 309.3% | 10 | Nov 19, 2024 | |
Lexeo Therapeutics | Maintains: Outperform | 20 19 | 5.87 | 223.68% | 2 | Nov 13, 2024 | |
Neurogene | Maintains: Outperform | 45 72 | 18.3 | 293.44% | 2 | Nov 12, 2024 | |
Camp4 Therapeutics | Initiates Coverage On: Outperform | 17 | 3.74 | 354.55% | 1 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 47 49 | 44.7 | 9.62% | 11 | Oct 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 47 46 | 35.67 | 28.96% | 15 | Oct 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 20 22 | 11.82 | 86.13% | 6 | Oct 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 9 8 | 6.59 | 21.4% | 7 | Sep 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | 53 62 | 33.49 | 85.13% | 15 | Jul 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 13 | 10.32 | 25.97% | 1 | Jul 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 29 | 19.82 | 46.32% | 1 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 165 230 | 120.97 | 90.13% | 1 | Jun 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 12 4 | 4.12 | -2.91% | 2 | Apr 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | n/a | n/a | n/a | 10 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 31 | 7.58 | 308.97% | 1 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 1 | 0.43 | 132.56% | 10 | Dec 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 7 | 1.47 | 376.19% | 1 | Nov 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 40 | 18.51 | 116.1% | 12 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 7 2 | n/a | n/a | 5 | Mar 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | 111 93 | 34.71 | 167.93% | 17 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 86 84 | 9.86 | 751.93% | 4 | Jan 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 6 7 | 1.23 | 469.11% | 4 | Jan 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 180 160 | 8.34 | 1818.47% | 10 | Jan 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 81 77 | 24.49 | 214.41% | 2 | Jan 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 144 143 | 250.03 | -42.81% | 11 | Jan 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 19 15 | n/a | n/a | 6 | Jan 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 77 14 | n/a | n/a | 4 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 5 6 | 5.2 | 15.38% | 5 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 75 76 | 39.72 | 91.34% | 1 | Nov 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 70 20 | n/a | n/a | 5 | Oct 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 30 34 | 1.6 | 2025% | 4 | May 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 6 1 | n/a | n/a | 3 | Feb 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 54 47 | n/a | n/a | 5 | Aug 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 50 20 | 4.4 | 354.55% | 6 | Jul 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 216 120 | n/a | n/a | 1 | May 3, 2021 |